Inovio Pharmaceuticals (INO) Current Deferred Revenue (2010 - 2022)
Inovio Pharmaceuticals (INO) recorded Current Deferred Revenue of $8.98 million in Q2 2022, compared with $109,128 a year earlier.
Powered by 
Analysis
Inovio Pharmaceuticals (INO) Current Deferred Revenue (2010 - 2022) Analysis & Trends
At the end of FY2021, Inovio Pharmaceuticals reported Current Deferred Revenue of $21,628, down 53.6% from FY2020.
- Annual Current Deferred Revenue has declined for five straight years, with a five-year compound annual growth rate of -72.9% (FY2016 to FY2021).
- Across earlier years, Current Deferred Revenue came in at $46,628 in FY2020 (-49.5%), $92,353 in FY2019 (-58.7%), $223,577 in FY2018 (-81.0%) and $1.18 million in FY2017 (-92.0%).
- The Q2 2022 figure is the highest quarterly Current Deferred Revenue since Q1 2018.
- On a year-over-year basis, Current Deferred Revenue rose in 1 of the last seven quarters, with growth averaging 61.1%.
- Peak year-over-year performance for Current Deferred Revenue in the last five years was growth of 634.7% in Q2 2021, against a decline of 99.5% in Q1 2019 at the low end.
- Per Business Quant, the preceding three quarters came in at $15,378 (Q1 2022), $21,628 (Q4 2021) and $77,878 (Q3 2021).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn |
| 10 | Inovio Pharmaceuticals | 99.58 Mn | 99.58 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2022 | 8.98 Mn |
| Mar 31, 2022 | 15,378.00 |
| Dec 31, 2021 | 21,628.00 |
| Sep 30, 2021 | 77,878.00 |
| Jun 30, 2021 | 109,128.00 |
| Mar 31, 2021 | 15,378.00 |
| Dec 31, 2020 | 46,628.00 |
| Sep 30, 2020 | 77,878.00 |
| Jun 30, 2020 | 14,853.00 |
| Mar 31, 2020 | 67,269.00 |
| Dec 31, 2019 | 92,353.00 |
| Sep 30, 2019 | 106,111.00 |
| Jun 30, 2019 | 120,694.00 |
| Mar 31, 2019 | 110,694.00 |
| Dec 31, 2018 | 223,577.00 |
| Sep 30, 2018 | 192,427.00 |
| Jun 30, 2018 | 762,361.00 |
| Mar 31, 2018 | 24.09 Mn |
| Dec 31, 2017 | 1.18 Mn |
| Sep 30, 2017 | 179,523.00 |
API Access
Inovio Pharmaceuticals Current Deferred Revenue API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=current-deferred-revenue&ticker=INO&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "current-deferred-revenue", "ticker": "INO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=current-deferred-revenue&ticker=INO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();